Product image of Irbesartan Aurovitas (Irbesartan) supplied by GNH India

Irbesartan Aurovitas

Active Ingredient:
Irbesartan
Origin:
EU

Irbesartan Aurovitas (Irbesartan)

Irbesartan, the active ingredient in Irbesartan Aurovitas, is an angiotensin II receptor blocker presented as an oral tablet for oral use. It is employed to manage high blood pressure and to protect kidney function in patients with diabetic nephropathy.
GNH India supplies Irbesartan Aurovitas as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Aurovitas Pharma Polska Sp. Z O.O

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Irbesartan belongs to the ARB class and is used to treat conditions related to the renin‑angiotensin system.
  • Hypertension: lowers elevated blood pressure and reduces cardiovascular risk.
  • Diabetic nephropathy: slows progression of kidney damage in patients with type 2 diabetes.

How It Works

  • Irbesartan selectively blocks the angiotensin II type 1 (AT1) receptor, preventing angiotensin II from binding. This inhibition reduces vasoconstriction, aldosterone secretion, and sympathetic activation, leading to vasodilation, decreased sodium and water retention, and ultimately lower blood pressure and renal protection.

Side Effects

Irbesartan may cause a range of adverse reactions, from mild to severe.

Common Side Effects

  • Dizziness or light‑headedness
  • Headache
  • Fatigue or weakness
  • Nausea or abdominal discomfort
  • Upper respiratory tract infection
  • Mild increase in serum potassium

Serious or Rare Side Effects

  • Angioedema involving face, lips, tongue or throat
  • Severe hypotension, especially in volume‑depleted patients
  • Acute kidney injury or worsening renal function
  • Hyperkalemia with potentially life‑threatening cardiac effects
  • Hepatic injury presenting as jaundice or elevated liver enzymes

Precautions & Warnings

Before initiating therapy, several safety considerations should be observed.

  • Blood pressure monitoring: check regularly to avoid excessive hypotension.
  • Renal function: assess serum creatinine and eGFR before and during treatment.
  • Serum potassium: monitor for hyperkalemia, especially with potassium‑sparing agents.
  • Hepatic impairment: use caution and adjust dose if liver disease is present.
  • Pregnancy: avoid use; potential fetal toxicity is not established.
  • Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Avoid Interactions

Irbesartan can interact with several drug classes, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid)

  • Concomitant use with aliskiren in diabetic patients: increased risk of renal impairment and hyperkalemia.
  • Dual blockade with ACE inhibitors or other ARBs: heightened risk of hypotension, renal dysfunction, and hyperkalemia.
  • Potassium‑sparing diuretics (e.g., spironolactone): may cause dangerous elevations in serum potassium.

Moderate Interactions (Monitor Closely)

  • Non‑steroidal anti‑inflammatory drugs (NSAIDs): can reduce antihypertensive effect and impair renal function.
  • Lithium: may increase lithium levels, leading to toxicity.
  • Diuretics (thiazides or loop): may enhance antihypertensive effect and affect electrolyte balance.

Frequently Asked Questions

Irbesartan Aurovitas is prescribed to lower high blood pressure (hypertension) and to slow the progression of kidney damage in patients with diabetic nephropathy. By controlling these conditions, it helps reduce the risk of cardiovascular events and renal failure.

Irbesartan blocks the angiotensin II type 1 (AT1) receptors, preventing angiotensin II from causing blood vessels to narrow and the adrenal glands from releasing aldosterone. This results in vessel relaxation, reduced fluid retention, and lower blood pressure, while also protecting kidney function.

The specific dose of Irbesartan Aurovitas is determined by the prescribing healthcare professional based on the patient’s medical condition, response to therapy, and other individual factors. Patients should follow the dosage instructions provided by their prescriber.

Irbesartan Aurovitas is generally not recommended during pregnancy because it may affect fetal development. Safety during breastfeeding has not been established, so the benefits and risks should be discussed with a healthcare provider before use.

To request Irbesartan Aurovitas, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Irbesartan belongs to the ARB class, which offers blood‑pressure control similar to ACE inhibitors but with a lower incidence of cough and angioedema. Compared with calcium‑channel blockers, ARBs primarily target the renin‑angiotensin system, making them especially useful for patients with diabetic kidney disease.

Irbesartan Aurovitas should be stored at room temperature, below 25 °C, in its original packaging. Keep the product away from moisture, direct sunlight, and excessive heat to maintain its stability and potency.

Irbesartan Aurovitas is taken orally, usually once daily, with or without food. The tablet should be swallowed whole with a glass of water and not chewed or crushed unless otherwise directed by a healthcare professional.

Serious risks include angioedema, severe hypotension, acute kidney injury, and hyperkalemia, which can lead to dangerous heart rhythm disturbances. Patients should seek immediate medical attention if they experience swelling of the face or throat, faintness, rapid weight gain, or muscle weakness.

Irbesartan Aurovitas should be avoided in patients with known hypersensitivity to irbesartan or any ARB components, those who are pregnant, and individuals with severe hepatic impairment. Caution is also advised for patients with existing kidney disease or elevated potassium levels.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Irbesartan

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT